TRANSL CANCER RES 润色咨询

Translational Cancer Research

出版年份:暂无数据 年文章数:2981 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:9.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=46a112743, cover=https://img.medsci.cn/images/journal/cover/2021/baz_202109271316439540.jpg, fullname=Translational Cancer Research, abbr=TRANSL CANCER RES, pyear=暂无数据, frequence=Bimonthly, articleNumbers=2981, citedSelf2015=9.2, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均3月, reviewFee=null, pageFee=1390.0, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2218-676X, greenSci=https://www.greensci.net/search?kw=2218-676X, scijournal=https://www.scijournal.org/impact-factor-of-TRANSL-CANCER-RES.shtml, medsciHotlightString=null, medsciHotlightRealtime=36.77, medsciHotlight=43.519, medsciHotlight5year=29.4766, citescore=0.0, hIndex=30, impactFactor=0.9, orgnization=AME Publishing Company, orgnizationUrl=http://amepc.org, country=China, countryCn=中国大陆, isOa=0, isOaString=否, sciScie=Science Citation Index Expanded, bigclassCas=医学 4区, smallclassCas=医学 4 区, website=http://tcr.amegroups.com/, websiteHits=16493, guideForAuthor=null, guideForAuthorHits=105, submitWebsite=https://www.thetcr.org/login?source=%2Fauthor%2Fsubmit, submitWebsiteHits=11018, content=Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; www.thetcr.org) is an Open Access, peer-reviewed journal, published by AME Publishing Company, publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. TCR will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving cancer patients lives. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles. The Official Publication of Society for Translational Cancer Research (STCR),Hong Kong, totalCites=2683, brief=TRANSL CANCER RES杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=肿瘤学" >肿瘤学</a></strong>”子行业的偏低级别杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #008000;">绿</span>, medsciComment=TRANSL CANCER RES是值得推荐的期刊,应该比较合适国人投稿,命中率也应该不会很低,MedSci强烈推荐此区杂志。但是也要关注MedSci其它提醒或警告。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=46a112743'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=9), ImpactFactorTagDto(id=439433, tagName=生信研究, createdHits=4), ImpactFactorTagDto(id=1608, tagName=转化医学, createdHits=2), ImpactFactorTagDto(id=482500, tagName=泛癌研究, createdHits=2), ImpactFactorTagDto(id=92682, tagName=单基因, createdHits=2), ImpactFactorTagDto(id=516, tagName=癌症, createdHits=1), ImpactFactorTagDto(id=429, tagName=肝癌, createdHits=1), ImpactFactorTagDto(id=313, tagName=临床, createdHits=1), ImpactFactorTagDto(id=7967, tagName=回顾性分析, createdHits=1), ImpactFactorTagDto(id=988, tagName=预后, createdHits=1), ImpactFactorTagDto(id=57838, tagName=生信, createdHits=1), ImpactFactorTagDto(id=116208, tagName=纯生信, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=1.36), GetImpactFactorCiteScoreListResponse(year=2017, citescore=0.48), GetImpactFactorCiteScoreListResponse(year=2018, citescore=0.44), GetImpactFactorCiteScoreListResponse(year=2019, citescore=0.9), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=42.012), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=41.516), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=50.102), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=47.387), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=36.77)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=261/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Radiology, Nuclear Medicine and Imaging , rank=226/272), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=174/191)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2218-676X[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Translational Cancer Research[ta], article_number=265, article_number_cn=237, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
TRANSL CANCER RES/Translational Cancer Research
ISSN
2218-676X
影响指数话题
预警等级
MedSci期刊指数
36.77 (MedSci实时期刊指数) | 29.4766 (5年期刊指数)
CiteScore值
0.0
h-index
30
h5-median
暂无数据
出版社/管理机构
杂志由 AME Publishing Company 出版或管理
出版国家/地区
China 中国大陆
出版周期
Bimonthly
出版年份
暂无数据
是否OA
被收录情况
Science Citation Index Expanded
JCR分区
暂无数据
中科院分区
大类:医学 4区
小类:医学 4 区